Top Safety Accreditation for Extract Technology Ltd
International business Extract Technology has been awarded accreditation from Safecontractor for its commitment to achieving excellence in health and safety.
Safecontractor is a leading third party accreditation scheme which recognises very high standards in health and safety management amongst UK companies.
Employing 65 people in Huddersfield, Extract Technology is principally involved in the life science sector, specialising in the containment and aseptic solutions for the pharmaceutical and biotech industries. Extract Technology’s most recent clients have included major players such as GlaxoSmithKline, Astra Zeneca, TEVA and Sandoz.
The company’s application for Safecontractor accreditation was driven by the need for a uniform standard across the business.
General Manager Alan Wainwright commented: “I would like to thank all those involved for their hard work in helping to achieve the standard. To gain accreditation to the scheme is another important achievement for our business and clearly demonstrates our commitment to health and safety within our organisation. Safecontractor accreditation not only supports our overall health and safety management practices but will enhance the company’s ability to attract new contracts.”
John Kinge, Technical Director of Safecontractor said: "Major organisations simply cannot afford to run the risk of employing contractors who are not able to prove that they have sound health and safety policies in place."
"More companies need to understand the importance of adopting good risk management in the way that Extract Technology has done. The firm’s high standard has set an example which hopefully will be followed by other companies within the sector.
Safecontractor plays a vital role in supporting our clients in meeting their compliance needs, whilst working with their contractors as they progress through the accreditation process.”
Under the Safecontractor scheme, businesses undergo a vetting process which examines health and safety procedures and their track record for safe practice. Those companies meeting the high standard are included on a database, which is accessible to registered users only via a website.
Client-organisations who sign up to the scheme can access the database, enabling them to audit potential contractors before they attend site. These clients agree that, as users of the scheme, they will engage only those who have received accreditation.
Over 210 major, nation-wide businesses, from several key sectors, have signed up to use the scheme when selecting contractors for services such as building, cleaning, maintenance, refurbishment or electrical and mechanical work.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance